Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Death meditation may cure phone addiction in young adults

NCT ID NCT07379541

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a special type of meditation—focusing on death—could help young adults (ages 18-29) reduce their smartphone addiction. 259 participants with problematic phone use were randomly assigned to either death-focused or traditional mindfulness meditation. The goal was to see if death meditation uniquely improved self-esteem, life meaning, and stress, leading to less phone use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

259 people

The number who actually took part.

Started

Feb 2025

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 29 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Inclusion criteria were adults aged 18-29 years who: * reported no current or past psychiatric diagnosis, * exhibited problematic smartphone use, * and had a mean daily screen-on time exceeding four hours. * Exclusion criteria were as follows: * aged \<18 or ≥30 years; * any current or past psychiatric diagnosis; * self-reported absence of problematic smartphone use; * mean daily smartphone use ≤4 hours; * currently enrolled in any meditation-based intervention; * use of psychoactive medication or concurrent psychological treatment; * participation in another psychological intervention trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Smartphone addiction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Internet Addiction Disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Normal University

    Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.